earnings
CR
NASDAQ · CRSP
CRISPR Therapeutics AG
Healthcare · Biotechnology
$56.98
Down-$0.16 (-0.28%)
Updated Sep 1, 2026, 8:23 PM
SID Score
5.5/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 5.08B
- P/E ratio
- -10.81
- Dividend yield
- 0.00%
- 52-week range
- $44.12 – $78.48
- Volume
- 1.39M
- Avg. volume
- 2.56M
Price performance
CRSP price history
1M range · 21 trading sessions · Daily adjusted prices
CRSP closed at $56.98 after 21 trading sessions, up 14.95% for the selected period.
- Last close
- $56.98
- Period change
- +14.95%
- Period low
- $49.57
- Period high
- $60.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 31, 2026 | $56.55 | $57.49 | $56.20 | $56.98 | 1.39M |
| Aug 28, 2026 | $58.22 | $59.3699 | $57.10 | $57.72 | 1.39M |
| Aug 27, 2026 | $59.12 | $60.11 | $58.02 | $59.37 | 1.19M |
| Aug 26, 2026 | $60.18 | $60.39 | $58.06 | $59.23 | 959.93K |
| Aug 25, 2026 | $57.93 | $61.55 | $57.5103 | $60.90 | 2.08M |
| Aug 24, 2026 | $58.75 | $58.9627 | $56.62 | $57.075 | 1.12M |
| Aug 21, 2026 | $59.72 | $62.535 | $58.89 | $59.50 | 2.45M |
| Aug 20, 2026 | $58.73 | $60.90 | $56.94 | $58.12 | 2.91M |
| Aug 19, 2026 | $55.00 | $59.915 | $54.985 | $59.81 | 3.84M |
| Aug 18, 2026 | $53.20 | $53.88 | $51.80 | $52.97 | 1.31M |
| Aug 17, 2026 | $53.08 | $54.57 | $52.61 | $54.28 | 958.15K |
| Aug 14, 2026 | $53.99 | $54.00 | $52.23 | $53.55 | 807.99K |
| Aug 13, 2026 | $54.28 | $54.70 | $53.50 | $53.99 | 909.13K |
| Aug 12, 2026 | $54.30 | $55.02 | $53.46 | $53.99 | 742.9K |
| Aug 11, 2026 | $53.88 | $54.685 | $53.12 | $54.07 | 1.07M |
| Aug 10, 2026 | $53.50 | $54.68 | $53.10 | $53.51 | 1.19M |
| Aug 7, 2026 | $52.58 | $54.17 | $52.18 | $53.52 | 1.28M |
| Aug 6, 2026 | $52.55 | $53.11 | $51.51 | $51.64 | 1.03M |
| Aug 5, 2026 | $53.00 | $53.33 | $51.81 | $52.45 | 1.62M |
| Aug 4, 2026 | $50.55 | $53.20 | $50.16 | $53.07 | 2.14M |
| Aug 3, 2026 | $48.04 | $49.90 | $47.5001 | $49.57 | 1.4M |
Latest CRSP news
The latest Smart Investors Daily articles mentioning CRSP.
Stock researchCompany · Financials
Loading stock research…